Exenatide versus glibenclamide in patients with diabetes von Derosa, G, Maffioli, P, Salvadeo, S A T, Ferrari, I, Ragonesi, P D, Querci, F, Franzetti, I G, Gadaleta, G, Ciccarelli, L, Piccinni, M N, D'Angelo, A, Cicero, A F G

Volltext

36 EVALUATION OF METALLOPROTEINASE 2 AND 9 LEVELS AND THEIR INHIBITORS IN COMBINED DYSLIPIDEMIA von Derosa, G, Maffioli, P, D'Angelo, A, Salvadeo, S.A.T, Ferrari, I, Fogari, E, Gravina, A, Mereu, R, Palumbo, I, Randazzo, S, Cicero, A.F.G

Volltext

35 EVALUATION OF METALLOPROTEINASE 2 AND 9 LEVELS AND THEIR INHIBITORS IN COMBINED DYSLIPIDEMIA DURING OMEGA-3 POLYUNSATURATED FATTY ACIDS THERAPY von Derosa, G, Maffioli, P, D'Angelo, A, Salvadeo, S.A.T, Ferrari, I, Fogari, E, Gravina, A, Mereu, R, Palumbo, I, Randazzo, S, Cicero, A.F.G

Volltext

PO9-200 INFLAMMATION MARKERS AND MMPS IN NONDIABETIC AND DIABETIC SUBJECTS DURING OGTT von Derosa, G., Cicero, A.F.G., DAngelo, A., Celentano, C., Fiorenza, A.M., Salvadeo, S.A.T., Pricolo, F., Ferrari, I., Gravina, A., Fogari, R.

Volltext

We-P11:65 Rosiglitazone therapy improves insulin resistance parameters in overweight and obese diabetic patients intolerant to metformin von Derosa, G., Salvadeo, S.A.T., D'Angelo, A., Ferrari, I., Ciccarelli, L., Piccinni, M.N., Pricolo, F., Ghelfi, M., Gravina, A., Ragonesi, P.D.

Volltext

PO22-698 EFFECT OF TELMISARTAN ON FASTING AND POSTPRANDIAL INFLAMMATION MARKERS IN DIABETIC HYPERTENSIVE PATIENTS von Derosa, G., Cicero, A.F.G., D'Angelo, A., Celentano, C., Fiorenza, A.M., Salvadeo, S.A.T., Pricolo, F., Ferrari, I., Gravina, A., Fogari, R.

Volltext